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Purpose: The small leucine-rich repeat proteins (SLRPs) are involved in organizing the collagen fibrils of the sclera and
vitreous. The shape of the eyeball is determined by the sclera and vitreous, so defects in SLRP family members may
contribute to myopia. The purpose of this study was to test whether mutations in the two members of the class III SLRPs,
opticin (OPTC) and dermatan sulfate proteoglycan 3 (EPYC), are responsible for high myopia.
Methods: DNA was prepared from venous leukocytes of 93 patients with high myopia (refraction of spherical equivalent
≤-6.00D) and 96 controls (refraction of spherical equivalent between -0.50D and +1.00D). The coding regions and adjacent
intronic sequences of OPTC and EPYC were amplified by the polymerase chain reaction (PCR), and the products were
then analyzed by cycle sequencing. The detected variations were further evaluated in normal controls and available family
members by a heteroduplex-single strand conformation polymorphism (heteroduplex-SSCP) analysis or sequencing.
Results: Two substitutions in OPTC, including c.491G>T and c.803T>C, were identified. The c.491G>T mutation
(p.Arg164Leu), a novel heterozygous variation, was detected in one of the 93 patients but in none of the 96 controls. The
c.803T>C mutation (p.Pro267Leu), a known polymorphism, was detected in 22 of the 93 patients and in 15 of 48 controls.
No variation was observed in EPYC.
Conclusions: Only one novel variation in OPTC was detected in a Chinese patient with high myopia. Our results imply that
OPTC and EPYC are unlikely to play a major role in high myopia.
Myopia is the most common human vision impairment
all over the world, especially in Chinese people living in
urban/suburban areas [1-6]. High myopia, an extreme form of
myopia with refraction less than -6.0D (diopters), is a common
cause of irreversible blindness due to its association with
retinal degeneration and detachment, glaucoma, and other
abnormalities. The exact molecular basis of high myopia and
the genes that cause a predisposition to this disorder are still
unknown, although abundant evidence has demonstrated that
genetic factors play an important role in the development of
high myopia [7].
The shape of the eye is largely determined by the sclera
and the vitreous that are composed of abundant extracellular
matrix (ECM) [8]. Abnormalities due to mutations in several
ECM  proteins  or  proteoglycans,  such  as  COL2A1  and
COL11A1  in  Stickler  syndrome  and  fibrillin-1  in  Marfan
syndrome, have been associated with syndromic high myopia
[9,10].  The  small  leucine-rich  repeat  proteins  (SLRPs),
members  of  the  ECM  family,  play  important  roles  in
organizing  collagen  fibrils  [11].  Experiments  in  SLRP
knockout mice have shown that a wide array of defects are
caused by abnormal collagen fibrillogenesis, resulting in a
longer eye axial length and high myopia [12]. Therefore, it
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would be reasonable to determine whether there are mutations
in these SLRPs in human subjects with high myopia.
The  OPTC  gene  (gene  ID:  26254;  OMIM  605127),
located in chromosome 1q32.1, is a member of the class III
SLRPs [13], and the OPTC protein is widely distributed in
ocular tissue, including the cornea, iris, trabecular meshwork,
ciliary body, retina, and optic nerve. OPTC is specifically
expressed in the vitreous humor where the protein plays a key
role in maintaining the gel structure of the vitreous humor
[14-16]. The dermatan sulfate proteoglycan 3 gene (DSPG3/
EPYC;  GENE  ID:  1833;  OMIM  601657),  located  in
chromosome 12q21 where MYP3 (OMIM 603221) mapped
[17,18], is another member of the class III SLRPs [19]. The
EPYC protein is predominantly expressed in cartilage [20,
21] and is important for fibrillogenesis through the regulation
of collagen fibrils.
In this study, the coding exons and the adjacent non-
coding  regions  of  OPTC  and  EPYC  were  analyzed  in  93
Chinese patients with high myopia.
METHODS
Subjects:  The  procedure  for  collecting  the  subjects  and
obtaining  informed  consent  was  the  same  as  previously
described [22]. The study was carried out following the tenets
of  the  Declaration  of  Helsinki  and  was  approved  by  the
Institute Review Board of the Zhongshan Ophthalmic Center.
Informed consent was obtained from the participating subjects
before  the  study.  Ophthalmological  examinations  were
performed by ophthalmologists of the Zhongshan Ophthalmic
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2045Center (Q.Z. and X.G.). The recruitment of subjects as same
as we described previously [23].
Mutation  analysis:  Genomic  DNA  was  prepared  from
peripheral leukocytes as described previously [24]. Table 1
lists the primers used to amplify the coding exons and adjacent
introns  of  OPTC  (NCBI  human  genome  build  36.3,
NC_000001.10 for genomic DNA, NM_ 014359.3 for mRNA
and  NP_  055174.1  for  protein)  and  EPYC  (NCBI  human
genome  build  36.2,  NC_000012.11  for  genomic  DNA,
NM_004950.4  for  mRNA  and  NP_004941.2  for  protein;
TABLE 1. PRIMERS USED FOR THE AMPLIFICATION AND SEQUENCING OF OPTC AND EPYC.
Gene Exon Direction Primer sequence
Size of PCR
product (bp)
Annealing temperature
(°C)
OPTC E2 F 5'-CGAGCCATTCCCACAACACT-3' 439 64
    R 5'-GCTGGAGACACCCGACTTT-3'
  E3 F 5'-TTCCCTCCTCCTCCTCCACA-3' 387 62
    R 5'-GTAGCCCTGACCCTCCAT-3'
  E4 F 5'-TGTACATGGTGCCCGTCAGT-3' 425 62
    R 5'-GAGAGCCAACAGGAAAGAGC-3'
  E5 F 5'-AGGTGGAGAGCTGGTTAGAA-3' 433 64
    R 5'-GGTGGTGGTGGAGGTGAGTG-3'
  E6 F 5'-GCGCATGGCTGAGGCTAAG-3' 346 62
    R 5'-CAATCAAGGAGACCCCACAG-3'
  E7 F 5'-TTGGCCCTAGATGCTTCAGT-3' 425 62
    R 5'-ATTAATGCCTGGGCTAAAGA-3'
  SSCP F 5'-CTGCGTGTGCCTCGGTTCCTCT-3' 180 64
    R 5'-ATGCCTGCCCCCACTCCTCTTT-3'
EPYC E2 F 5'-ACATCTGGCAGCAATGGTC-3' 538 60
    R 5'-TCCGGTATTAACCTCCAAAAG-3'
  E3 F 5'-CAAGCAGGATGGTCAAACTAT-3' 451 62
    R 5'-TGCTTCAAACCTAGCCTATTC-3'
  E4 F 5'-CTTGGTTAGTGGGAGACTCTA-3' 371 62
    R 5'-AACCAGGCTTTGGCATTCAA-3'
  E5-1* F 5'-ATTAACTGTGCATTGCTAAAT-3' 473 44-68
    R 5'-AAGCCTGGGTGACAGAGTGA-3'
  E5-2* F 5'-TAATGCCTGTATCTTTGACTAT-3' 630 44-68
    R 5'-AATTTATTTTCCCTACACGA-3'
  E5-3* F 5'-GTTGCTTTATGATGGATGAATG-3' 979 44-46
    R 5'-CCTAGGAAATATGGCGAAACC-3'
  E5-4 [25] F 5'-CGTGGTGTACCAATTTCTTTGCT-3' 579 44-68
    R 5'-ACTCAAGCCTGGGTGACAGAGTG-3'
  E6 F 5'-AAAACTAAGCTGCCTCAACT-3' 353 60
    R 5'-AACATGCCATTACAGACAAA-3'
  E7 F 5'-TTACCCCCATTGCTTAGAAA-3' 433 60
    R 5'-GAACACAATCTCAAAGTATCA-3'
The asterisk indicates that in order to amplify exon 5 of EPYC, the PCR conditions, including DMSO concentration, and the
enzymes used (rTaq, LATaq, hotMaster, and AmpiTaq Gold), were varied.
Figure 1. The exon-intron structures of OPTC and EYPC. The black rectangles represent the untranslated region and the green rectangles
represent the coding region.
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2046Figure 1). The nucleotide sequences of OPTC and EPYC were
determined by cycle sequencing. The sequencing results from
patients as well as the OPTC (NT_004487.19) and EPYC
(NT_029419.12)  consensus  sequences  were  compared  to
identify  variations.  The  variations  were  confirmed  by  bi-
directional  sequencing.  The  description  of  the  variations
followed  the  nomenclature  recommended  by  the  Human
Genomic  Variation  Society  (HGVS).  The  mutation  we
detected  was  further  evaluated  in  96  normal  controls  by
single-strand conformational polymorphism (SSCP) using an
extra pair of primers (Table 1), using the method we described
previously [24]. The SIFT program (Sorting Intolerant From
Tolerant)  was  used  to  predict  whether  an  amino  acid
substitution was likely to affect the protein function [26].
RESULTS
After  sequencing  the  OPTC  gene  from  93  high  myopia
patients, two missense variations, c.491G>T and c.803T>C,
were  identified.  The  c.491G>T  mutation  is  a  novel
heterozygous variation in which an arginine (a charged amino
acid)  would  be  replaced  by  a  leucine  (an  aliphatic,
hydrophobic  amino  acid)  in  the  encoded  protein
(p.Arg164Leu;  Figure  2A),  with  a  residue  weight  of  -2
(Blosum  62).  The  arginine  at  position  164  of  OPTC  is
conserved  among  the  six  orthologs  from  Homo  sapiens
(NP_055174),  Bos  Taurus  (NP_991339),  Canis  lupus
familiaris (NP_001003056), Gallus gallus (NP_989804), Sus
scrofa  (NP_999173),  and  Xenopus  tropicalis
(NP_001016499; Figure 2B), but is not conserved in two
orthologs from Mus Musculus (NP_473417) and Zebrafish
(NP_001003583).  The  SIFT  analysis  predicted  that  the
substitution at position 164 from arginine to leucine would to
be tolerated with a score of 0.17. Substitutions with a score
less than 0.05 are predicted to affect protein function [26].
This novel variant was identified only in a single patient, but
not  in  the  96  controls,  by  SSCP  analysis  (Figure  2C).
Figure 2. The novel variation identified
in  OPTC.  A:  The  c.491G>T  variant
(indicated by an arrow) was sequenced
in two directions and was compared to
the  wild  type  sequences.  B:  The
missense  variation  p.Arg164Leu  (c.
491G>T;  indicated  by  an  arrow)
changed  a  highly  conserved  residue
from arginine to leucine. C: Variant c.
491G>T  (p.Arg164Leu)  was  not
observed in the 96 normal controls by
the heteroduplex-SSCP analysis.
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2047However, the c.803T>C mutation (p.Pro267Leu), a known
polymorphism, was detected in 22 of the 93 patients with high
myopia (18 heterozygous and 4 homozygous) as well as in 15
of the 48 controls (13 heterozygous and 2 homozygous).
No variation was identified in exons 2, 3, 4, 6, and 7 of
EPYC. Our attempts to amplify part or all of exon 5 of EPYC
failed, possibly due to special DNA structures in the region,
such as those caused by a high AT content.
DISCUSSION
OPTC is widely expressed in ocular tissue and was screened
as a candidate gene in patients with high myopia, glaucoma,
and  age-related  macular  degeneration  [27-30].  Recently,
mutations in OPTC were suggested to be genetic risk factors
underlying  the  pathogenesis  of  high  myopia,  where  five
variations were identified in five of 125 Caucasian patients
with high myopia [30]. Co-segregation analyses were carried
out  in  four  families,  where  three  variants  (p.Arg325Trp,
p.Arg330His, and p.Gly329Ser) were also present in relatives
with normal refraction or moderate myopia. The p.Thr177Arg
variation was only detected in the proband but not in the
affected offspring. Incomplete penetrance was suggested as
an explanation for the presence of the variation in unaffected
family members [30].
In  this  study,  only  one  novel  variation  (c.491G>T,
p.Arg164Leu) was detected in one of the 93 patients with high
myopia.  The  protein  information  analysis  using  the  SIFT
program  indicated  that  the  p.Arg164Leu  variation  was
unlikely  to  affect  protein  function,  and  the  effect  of  this
variation was similar to the effects seen in Mus musculus
(p.Arg164His) or Zebrafish (p.Arg164Lys). However, it is
impossible to confirm or deny the association of this variation
with high myopia based on the current evidence, especially
because of our limited understanding of complex diseases. In
addition to the novel variant, a known c.803T>C variation was
detected in 22 of the 93 patients as well as in 15 of the 48
controls. The genotype and allele frequencies of this variation
were  similar  between  the  patients  and  controls  (χ2  test,
p=0.6175,  and  p=0.3529  separately).  This  variation  was
previously  detected  in  ten  Caucasian  patients  with  high
myopia as well as in 27 normal controls [30], suggesting that
this variation is more likely to be a polymorphism.
EPYC  (DSPG3),  located  in  the  mapping  interval  of
MYP3,  has  been  suggested  as  a  candidate  gene  for  high
myopia  [17].  An  analysis  of  four  single  nucleotide
polymorphisms  (SNPs:  rs1135866,rs1920748,rs1920751,
and rs1920752) in EPYC was performed for 120 patients with
high myopia and 137 controls, but no association was detected
[31].  However,  an  evaluation  of  the  coding  and  adjacent
intronic sequences of EPYC has not reported in patients with
high myopia thus far. In this study, no variation was detected
in the sequences of five of the six coding and adjacent intronic
regions of EPYC in 93 Chinese patients with high myopia. The
PCR  amplification  of  exon  5  of  EPYC  was  unsuccessful
despite  the  use  of  several  primer  pairs  and  different
amplification conditions. An extremely high AT content in
this region may be the cause of the difficulty with the PCR
amplification.
In summary, our results suggest that both OPTC and
EPYC  are  unlikely  to  play  a  major  role  in  high  myopia.
Additional studies will be necessary to clarify these results.
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